{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Setup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, json\n",
    "\n",
    "from langchain.vectorstores import FAISS\n",
    "from langchain.embeddings import OpenAIEmbeddings\n",
    "from langchain.embeddings.base import Embeddings\n",
    "\n",
    "import numpy as np\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of test cases: 30\n",
      "Length of embeddings: 1536\n"
     ]
    }
   ],
   "source": [
    "MAIN_DIR = \"..\"\n",
    "EMB_DIR = os.path.join(MAIN_DIR, \"data\", \"emb_store\", \"uc\", \"faiss\", \"text-embedding-ada-002\")\n",
    "\n",
    "with open(os.path.join(MAIN_DIR, \"auth\", \"api_keys.json\"), \"r\") as f:\n",
    "    api_keys = json.load(f)\n",
    "    \n",
    "os.environ[\"OPENAI_API_KEY\"] = api_keys[\"OPENAI_API_KEY\"]\n",
    "\n",
    "with open(os.path.join(MAIN_DIR, \"data\", \"queries\", \"uc_all.txt\"), \"r\") as f:\n",
    "    test_cases_txt = f.readlines()\n",
    "    \n",
    "with open(os.path.join(MAIN_DIR, \"data\", \"queries\", \"uc_all_emb.json\"), \"r\") as f:\n",
    "    test_cases_emb = json.load(f)\n",
    "    \n",
    "test_cases = [(txt, emb) for txt, emb in zip(test_cases_txt, test_cases_emb)]\n",
    "print(\"Number of test cases:\", len(test_cases))\n",
    "print(\"Length of embeddings:\", len(test_cases[0][1]))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Inspect Single Database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "embedding_function = OpenAIEmbeddings().embed_query\n",
    "docsearch = FAISS.load_local(\n",
    "    os.path.join(EMB_DIR, \"v8-add-tables_2500_500\"),\n",
    "    OpenAIEmbeddings()\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [],
   "source": [
    "k = 10\n",
    "\n",
    "info = {\n",
    "    \"question\": [],\n",
    "    \"average_score\": [],\n",
    "    \"min_score\": [],\n",
    "    \"max_score\": []\n",
    "}\n",
    "\n",
    "for idx in range(10):\n",
    "    info[f\"Doc {idx+1} text\"] = []\n",
    "    info[f\"Doc {idx+1} score\"] = []\n",
    "\n",
    "for test_case in test_cases:\n",
    "    info[\"question\"].append(test_case[0])\n",
    "    relevant_docs_and_scores = docsearch.similarity_search_with_score_by_vector(test_case[1], k = k)\n",
    "    scores = [doc_and_score[1] for doc_and_score in relevant_docs_and_scores]\n",
    "    info[\"average_score\"].append(np.mean(scores))\n",
    "    info[\"min_score\"].append(np.min(scores))\n",
    "    info[\"max_score\"].append(np.max(scores))\n",
    "    for idx, doc_and_score in enumerate(relevant_docs_and_scores):\n",
    "        doc, score = doc_and_score\n",
    "        info[f\"Doc {idx+1} text\"].append(doc.page_content)\n",
    "        info[f\"Doc {idx+1} score\"].append(score)\n",
    "        \n",
    "df = pd.DataFrame(info)\n",
    "save_folder = os.path.join(MAIN_DIR, \"artifacts\", \"similarity-search-analysis-text-embedding-ada-002\")\n",
    "if not os.path.exists(save_folder):\n",
    "    os.makedirs(save_folder, exist_ok=True)\n",
    "df.to_csv(os.path.join(save_folder, \"summary.csv\"),\n",
    "          header=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Compare Multiple Databases"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [],
   "source": [
    "docstores = [\n",
    "    \"v6-add-tables_750_100\",\n",
    "    \"v7-add-tables_1000_200\",\n",
    "    \"v8-add-tables_2500_500\",\n",
    "    \"v9-add-tables_1500_300\"\n",
    "]\n",
    "\n",
    "info = {\n",
    "    \"question\": [test_case[0] for test_case in test_cases],\n",
    "}\n",
    "\n",
    "for docstore in docstores:\n",
    "    docsearch = FAISS.load_local(\n",
    "        os.path.join(EMB_DIR, docstore),\n",
    "        OpenAIEmbeddings()\n",
    "        )\n",
    "    chunk_size = docstore.split(\"_\")[-2]\n",
    "    info[f\"{chunk_size}_average_score\"] = []\n",
    "    info[f\"{chunk_size}_min_score\"] = []\n",
    "    info[f\"{chunk_size}_max_score\"] = []\n",
    "    \n",
    "    for test_case in test_cases:\n",
    "        relevant_docs_and_scores = docsearch.similarity_search_with_score_by_vector(test_case[1], k = k)\n",
    "        scores = [doc_and_score[1] for doc_and_score in relevant_docs_and_scores]\n",
    "        info[f\"{chunk_size}_average_score\"].append(np.mean(scores))\n",
    "        info[f\"{chunk_size}_min_score\"].append(np.min(scores))\n",
    "        info[f\"{chunk_size}_max_score\"].append(np.max(scores))\n",
    "        \n",
    "df_scores = pd.DataFrame(info)\n",
    "save_folder = os.path.join(MAIN_DIR, \"artifacts\", \"similarity-search-analysis-text-embedding-ada-002\")\n",
    "if not os.path.exists(save_folder):\n",
    "    os.makedirs(save_folder, exist_ok=True)\n",
    "    \n",
    "df_scores.to_csv(os.path.join(save_folder, \"compare_database.csv\"),\n",
    "                 header=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Inspect Table Contents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.document_loaders import PyMuPDFLoader\n",
    "\n",
    "page_no = 5\n",
    "document = os.path.join(\n",
    "    os.path.join(MAIN_DIR, \"data\", \"document_store\", \"uc\", \"1-s2.0-S2468125321003770-main.pdf\")\n",
    ")\n",
    "\n",
    "docs = PyMuPDFLoader(document).load()\n",
    "page_with_table = docs[page_no-1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Articles\n",
      "www.thelancet.com/gastrohep   Vol 7   February 2022 \n",
      "165\n",
      "U-ACCOMPLISH8). No phase 3 RCTs with etrasimod or \n",
      "TD-1473 were found.\n",
      "Among 22 studies evaluating maintenance therapy, ten \n",
      "were done by use of a treat-straight-through strategy \n",
      "(2528 patients)19–22,24,25,29,34,36 and 12 followed a randomised \n",
      "responders design (3484 patients).6,27,28,30–32,35,37–41 Only seven \n",
      "studies evaluated histological remission.6,29,31,32,35,38,41 The \n",
      "main characteristics of the included trials are described \n",
      "in the appendix (pp 2–4). All outcomes were assessed \n",
      "uniformly on the basis of the standard definition of the \n",
      "Mayo score, with follow-up durations of 6–14 weeks for \n",
      "induction therapy and 26–66 weeks for maintenance \n",
      "therapy (appendix pp 2–4). All studies were industry \n",
      "sponsored. A risk of bias assessment showed a low risk \n",
      "of bias for most of the included studies (appendix p 5). \n",
      "Confidence in the estimates derived from our meta-\n",
      "analysis is shown in the appendix (pp 6–8).\n",
      "A network map of induction trials assessing clinical \n",
      "remission in patients with moderate-to-severe ulcerative \n",
      "colitis is shown in figure 2. When evaluating the \n",
      "induction of clinical remission, all interventions, except \n",
      "for filgotinib 100 mg (OR 1·55, 95% CI 0·98–2·46), were \n",
      "significantly superior to placebo in the direct, pairwise \n",
      "meta-analysis (appendix p 9); overall heterogeneity was \n",
      "substantial (I²=81%). The results from our network meta-\n",
      "analysis are shown in figure 3. When comparing active \n",
      "treatments, adalimumab (OR 0·54, 95% CI 0·37–0·79; \n",
      "moderate confidence), etrolizumab (0·51, 0·36–0·72; \n",
      "high confidence), filgotinib 100 mg (0·41, 0·23–0·71; \n",
      "moderate confidence), and filgotinib 200 mg (0·56, \n",
      "0·32–0·97; moderate confidence) were significantly \n",
      "inferior to infliximab in inducing clinical remission. \n",
      "Ozanimod (OR 2·27, 95% CI 1·05–4·89; moderate \n",
      "confidence), tofacitinib (0·46, 0·22–0·95; moderate \n",
      "confidence), \n",
      "and \n",
      "ustekinumab \n",
      "(0·47, \n",
      "0·22–0·99; \n",
      "moderate confidence) were significantly superior to \n",
      "filgotinib 100 mg. Upadacitinib was significantly superior \n",
      "to all other interventions (figure 3; moderate-to-high \n",
      "confidence) and ranked highest for the induction of \n",
      "clinical remission (SUCRA 0·996), followed by infliximab \n",
      "(0·771; appendix p 10).\n",
      "When evaluating the induction of endoscopic \n",
      "improvement, all interventions, except for filgotinib \n",
      "100 mg (OR 1·38, 95% CI 0·61–3·14), were signifi cantly \n",
      "superior to placebo in the direct, pairwise meta-analysis; \n",
      "overall heterogeneity was substantial (I²=80%; appendix \n",
      "p 11). In our network meta-analysis, in direct comparison \n",
      "of active treat ments showed that adalimumab (mode rate \n",
      "Figure 3: Indirect comparison of biologics and small molecule drugs for the induction of clinical remission and endoscopic improvement in patients with moderate-to-severe ulcerative colitis \n",
      "(overall population) in a network meta-analysis\n",
      "Comparisons should be read from left to right; to obtain odds ratios from right to left, reciprocals should be taken. The odds ratio (95% CI) for comparisons are in the cell in common between the \n",
      "column-defining and row-defining treatments. The violet boxes represent statistically significant comparisons and the white boxes represent non-statistically significant comparisons. \n",
      "Endoscopic improvement\n",
      "8·23\n",
      "(5·32–12·75)\n",
      "2·74\n",
      "(1·72–4·34)\n",
      "2·82\n",
      "(1·30–6·12)\n",
      "1·38\n",
      "(0·60–3·14)\n",
      "2·71\n",
      "(1·81–4·02)\n",
      "1·74\n",
      "(1·34–2·26)\n",
      "1·74\n",
      "(1·34–2·26)\n",
      "1·74\n",
      "(1·22–2·49)\n",
      "1·82\n",
      "(1·25–2·63)\n",
      "1·52\n",
      "(1·21–1·92)\n",
      "3·00\n",
      "(2·33–3·82)\n",
      "Placebo\n",
      "2·75\n",
      "(1·66–4·55)\n",
      "0·91\n",
      "(0·54–1·54)\n",
      "0·94\n",
      "(0·41–2·14)\n",
      "0·46\n",
      "(0·19–1·09)\n",
      "0·90\n",
      "(0·56–1·44)\n",
      "0·58\n",
      "(0·43–0·78)\n",
      "0·79\n",
      "(0·49–1·27)\n",
      "0·58\n",
      "(0·37–0·91)\n",
      "0·60\n",
      "(0·39–0·95)\n",
      "0·51\n",
      "(0·37–0·69)\n",
      "Inﬂiximab\n",
      "3·76\n",
      "(2·77–5·12)\n",
      "5·41\n",
      "(3·30–8·86)\n",
      "1·79\n",
      "(1·07–3·01)\n",
      "1·85\n",
      "(0·82–4·15)\n",
      "0·90\n",
      "(0·38–2·12)\n",
      "1·77\n",
      "(1·11–2·81)\n",
      "1·14\n",
      "(0·88–1·49)\n",
      "1·56\n",
      "(0·98–2·48)\n",
      "1·15\n",
      "(0·75–1·75)\n",
      "1·19\n",
      "(0·77–1·84)\n",
      "Adalimumab\n",
      "0·54\n",
      "(0·37–0·79)\n",
      "2·05\n",
      "(1·54–2·73)\n",
      "4·52\n",
      "(2·55–8·01)\n",
      "1·50\n",
      "(0·83–2·72)\n",
      "1·54\n",
      "(0·65–3·65)\n",
      "0·75\n",
      "(0·30–1·86)\n",
      "1·48\n",
      "(0·86–2·55)\n",
      "0·95\n",
      "(0·61–1·51)\n",
      "1·31\n",
      "(0·76–2·26)\n",
      "0·95\n",
      "(0·57–1·60)\n",
      "Golimumab\n",
      "1·54\n",
      "(0·79–3·01)\n",
      "0·84\n",
      "(0·43–1·65)\n",
      "3·17\n",
      "(1·74–5·79)\n",
      "4·71\n",
      "(2·68–8·28)\n",
      "1·56\n",
      "(0·87–2·81)\n",
      "1·61\n",
      "(0·68–3·79)\n",
      "0·79\n",
      "(0·32–1·93)\n",
      "1·54\n",
      "(0·90–2·63)\n",
      "1·00\n",
      "(0·64–1·55)\n",
      "1·36\n",
      "(0·79–2·33)\n",
      "Vedolizumab\n",
      "0·84\n",
      "(0·41–1·68)\n",
      "1·30\n",
      "(0·96–1·74)\n",
      "0·71\n",
      "(0·45–1·10)\n",
      "2·67\n",
      "(1·87–3·80)\n",
      "3·45\n",
      "(1·90–6·24)\n",
      "1·14\n",
      "(0·62–2·11)\n",
      "1·18\n",
      "(0·49–2·83)\n",
      "0·57\n",
      "(0·23–1·44)\n",
      "1·13\n",
      "(0·64–1·99)\n",
      "0·73\n",
      "(0·45–1·18)\n",
      "Ustekinumab\n",
      "1·22\n",
      "(0·62–2·39)\n",
      "1·02\n",
      "(0·44–2·35)\n",
      "1·59\n",
      "(0·83–3·02)\n",
      "0·86\n",
      "(0·45–1·66)\n",
      "3·26\n",
      "(1·83–5·79)\n",
      "4·71\n",
      "(2·83–7·83)\n",
      "1·56\n",
      "(0·92–2·66)\n",
      "1·61\n",
      "(0·71–3·65)\n",
      "0·78\n",
      "(0·33–1·86)\n",
      "1·54\n",
      "(0·96–2·48)\n",
      "Etrolizumab\n",
      "0·59\n",
      "(0·31–1·14)\n",
      "0·72\n",
      "(0·48–1·08)\n",
      "0·61\n",
      "(0·31–1·21)\n",
      "0·94\n",
      "(0·69–1·29)\n",
      "0·51\n",
      "(0·36–0·72)\n",
      "1·94\n",
      "(1·42–2·64)\n",
      "3·05\n",
      "(1·68–5·51)\n",
      "1·01\n",
      "(0·55–1·86)\n",
      "1·04\n",
      "(0·43–2·50)\n",
      "0·51\n",
      "(0·20–1·27)\n",
      "Tofacitinib\n",
      "1·72\n",
      "(0·90–3·29)\n",
      "1·02\n",
      "(0·45–2·30)\n",
      "1·25\n",
      "(0·64–2·45)\n",
      "1·05\n",
      "(0·46–2·41)\n",
      "1·63\n",
      "(0·86–3·08)\n",
      "0·89\n",
      "(0·46–1·69)\n",
      "3·35\n",
      "(1·90–5·91)\n",
      "5·96\n",
      "(2·35–15·14)\n",
      "1·98\n",
      "(0·77–5·09)\n",
      "2·04\n",
      "(0·66–6·33)\n",
      "Filgotinib\n",
      "100 mg\n",
      "0·46\n",
      "(0·22–0·95)\n",
      "0·79\n",
      "(0·45–1·39)\n",
      "0·47\n",
      "(0·22–0·99)\n",
      "0·57\n",
      "(0·32–1·03)\n",
      "0·48\n",
      "(0·22–1·03)\n",
      "0·75\n",
      "(0·43–1·30)\n",
      "0·41\n",
      "(0·23–0·71)\n",
      "1·54\n",
      "(0·97–2·45)\n",
      "2·91\n",
      "(1·19–7·10)\n",
      "0·97\n",
      "(0·39–2·39)\n",
      "Filgotinib\n",
      "200 mg\n",
      "1·37\n",
      "(0·71–2·62)\n",
      "0·63\n",
      "(0·30–1·31)\n",
      "1·09\n",
      "(0·63–1·89)\n",
      "0·65\n",
      "(0·31–1·35)\n",
      "0·79\n",
      "(0·44–1·41)\n",
      "0·66\n",
      "(0·31–1·42)\n",
      "1·03\n",
      "(0·60–1·77)\n",
      "0·56\n",
      "(0·32–0·97)\n",
      "2·12\n",
      "(1·34–3·35)\n",
      "3·01\n",
      "(1·59–5·67)\n",
      "Ozanimod\n",
      "1·65\n",
      "(0·77–3·55)\n",
      "2·27\n",
      "(1·05–4·89)\n",
      "1·05\n",
      "(0·45–2·41)\n",
      "1·81\n",
      "(0·91–3·60)\n",
      "1·07\n",
      "(0·46–2·49)\n",
      "1·31\n",
      "(0·65–2·67)\n",
      "1·10\n",
      "(0·47–2·61) \n",
      "1·71\n",
      "(0·87–3·37)\n",
      "0·93 \n",
      "(0·47–1·85)\n",
      "3·52\n",
      "(1·91–6·49)\n",
      "Upadacitinib\n",
      "2·70\n",
      "(1·18–6·20)\n",
      "4·49\n",
      "(2·18–9·24)\n",
      "6·15\n",
      "(2·98–12·72)\n",
      "2·84\n",
      "(1·28–6·31)\n",
      "4·91\n",
      "(2·59–9·31)\n",
      "2·92\n",
      "(1·31–6·51)\n",
      "3·56\n",
      "(1·84–6·91)\n",
      "3·00\n",
      "(1·32–6·82)\n",
      "4·64\n",
      "(2·47–8·71)\n",
      "2·70\n",
      "(1·18–6·20)\n",
      "9·54\n",
      "(5·45–16·69)\n",
      "Clinical remission\n",
      "See Online for appendix\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(page_with_table.page_content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.document_loaders import CSVLoader, UnstructuredCSVLoader\n",
    "from langchain.docstore.document import Document\n",
    "\n",
    "table_path = os.path.join(MAIN_DIR, \"data\", \"tables\", \"uc_juillerat_2022_tab1.csv\")\n",
    "table = CSVLoader(table_path, encoding = \"ISO-8859-1\")\n",
    "unstructured_table = UnstructuredCSVLoader(\n",
    "    table_path, mode = \"single\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Table Description: Efficacy of biological treatments according, to the line of treatment, earlier exposure, disease phenotype and patient characteristics. \n",
      "\n",
      "Table Content:\n",
      "Patient Profile: Fresh No previous treatment\n",
      "Best: Infliximab (IFX*)\n",
      "2nd Best: Vedoluzimab (VEDO)\n",
      "3rd Best: Ustekinumab (USTE)\n",
      "4th Best: Golimumab (GOL)\n",
      "5th Best: Adalimumab (ADA)\n",
      "\n",
      "Patient Profile: Currently under maintenance\n",
      "Best: Vedoluzimab (VEDO)\n",
      "2nd Best: Infliximab (IFX)\n",
      "3rd Best: Ustekinumab (USTE), Golimumab (GOL)\n",
      "4th Best: Adalimumab (ADA)\n",
      "5th Best: \n",
      "\n",
      "Patient Profile: Prior response to Infliximab\n",
      "Best: Golimumab (GOL)\n",
      "2nd Best: Adalimumab (ADA)\n",
      "3rd Best: Ustekinumab (USTE), Vedoluzimab (VEDO)\n",
      "4th Best: \n",
      "5th Best: \n",
      "\n",
      "Patient Profile: Prior failure to Anti-TNF agents (1-2x) (PNR)\n",
      "Best: Ustekinumab (USTE)\n",
      "2nd Best: Vedoluzimab (VEDO)\n",
      "3rd Best: \n",
      "4th Best: \n",
      "5th Best: \n",
      "\n",
      "Patient Profile: Prior failure to Vedolizumab\n",
      "Best: Infliximab (IFX)\n",
      "2nd Best: Ustekinumab (USTE), Golimumab (GOL)\n",
      "3rd Best: Adalimumab (ADA)\n",
      "4th Best: \n",
      "5th Best: \n",
      "\n",
      "Patient Profile: Age > 65 & comorbidities (safety aspects data)\n",
      "Best: Ustekinumab (USTE), Vedoluzimab (VEDO)\n",
      "2nd Best: Golimumab (GOL), Infliximab (IFX), Adalimumab (ADA)\n",
      "3rd Best: \n",
      "4th Best: \n",
      "5th Best: \n",
      "\n",
      "Patient Profile: Pregnancy\n",
      "Best: Infliximab (IFX)\n",
      "2nd Best: Golimumab (GOL), Adalimumab (ADA)\n",
      "3rd Best: Ustekinumab (USTE), Vedoluzimab (VEDO)\n",
      "4th Best: \n",
      "5th Best: \n",
      "\n",
      "Patient Profile: Extraintestinale manifestation\n",
      "Best: Infliximab (IFX)\n",
      "2nd Best: Golimumab (GOL)\n",
      "3rd Best: Adalimumab (ADA)\n",
      "4th Best: Ustekinumab (USTE)\n",
      "5th Best: Vedoluzimab (VEDO)\n",
      "\n",
      "Patient Profile: Pouchitis\n",
      "Best: Vedoluzimab (VEDO)\n",
      "2nd Best: Adalimumab (ADA)\n",
      "3rd Best: Infliximab (IFX)\n",
      "4th Best: Ustekinumab (USTE)\n",
      "5th Best: Golimumab (GOL)\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "docs = table.load()\n",
    "table_content = (\n",
    "    \"Table Description: Efficacy of biological treatments according, \"\n",
    "    \"to the line of treatment, earlier exposure, disease phenotype \"\n",
    "    \"and patient characteristics. \\n\\nTable Content:\\n\"\n",
    "    )  \n",
    "for row in docs:\n",
    "    table_content += row.page_content + \"\\n\\n\"\n",
    "\n",
    "table_doc = Document(page_content=table_content)\n",
    "\n",
    "print(table_content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.prompts.chat import ChatPromptTemplate\n",
    "\n",
    "from langchain.prompts.chat import (\n",
    "    ChatPromptTemplate,\n",
    "    HumanMessagePromptTemplate,\n",
    "    SystemMessagePromptTemplate,\n",
    ")\n",
    "\n",
    "# CHAT PROMTP TEMPLATE\n",
    "system_prompt = \"\"\"\n",
    "You are a physician assistant giving advice on treatment for moderate to severe ulcerative colitis (UC).\n",
    "Make reference to the CONTEXT given to assess the scenario.\n",
    "If the answer cannot be inferred from CONTEXT, return \"NO ANSWER\", don't try to make up an answer.\n",
    "=================================\n",
    "TASK: ANALYSE the given patient profile based on given query based on one of the following criteria:\n",
    "- Whether treated patient is new patient or patient under maintenance\n",
    "- Prior response to Infliximab\n",
    "- Prior failure to Anti-TNF agents\n",
    "- Prior failure to Vedolizumab\n",
    "- Age\n",
    "- Pregnancy\n",
    "- Extraintestinale manifestations\n",
    "- Pouchitis\n",
    "\n",
    "FINALLY RETURN up to 2 TOP choices of biological drugs given patient profile and context. Explain the PROS and CONS of the 2 choices.\n",
    "If answer cannot be derived from context, RETURN \"NO ANSWER\" and explain reason.\n",
    "=================================\n",
    "OUTPUT INSTRUCTIONS:\n",
    "Output your answer as a list of JSON objects with keys: drug_name, advantages, disadvantages.\n",
    "=================================\n",
    "CONTEXT:\n",
    "{summaries}\n",
    "=================================\n",
    "\"\"\"\n",
    "\n",
    "PROMPT_TEMPLATE = ChatPromptTemplate.from_messages(\n",
    "    [\n",
    "        SystemMessagePromptTemplate.from_template(\n",
    "            system_prompt, input_variables=[\"summaries\"]\n",
    "        ),\n",
    "        HumanMessagePromptTemplate.from_template(\"PATIENT PROFILE: {question}\"),\n",
    "    ]\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.chains.qa_with_sources import load_qa_with_sources_chain\n",
    "from langchain.chat_models import ChatOpenAI\n",
    "\n",
    "qa_chain = load_qa_with_sources_chain(\n",
    "    llm=ChatOpenAI(temperature=0, model_name=\"gpt-3.5-turbo\", max_tokens=512),\n",
    "    \n",
    ")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
